Database for Interstitial Lung Disease
ConditionLung Diseases, Interstitial
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorMedical University of Graz
About this trial
The purpose of this study is to establish a clinical database for patients bearing at risk for ILD (Interstitial Lung Disease) and to set up a prospective ILD Screening program for these patients.
Eligibility criteria
Qualifiers
Age: ≥ 18 years
patients with a known systemic disease bearing a risk for ILD
signed informed consent (for prospective part)
Disqualifiers
Age < 18 years
comorbidities severely limiting life-expectancy (e.g. severe cardiovascular conditions, malignant disease)
Trial design
Treatments tested in this trial
- chest CT
Treatment groups
412 Participants
are divided into 2 treatment groupsSponsors and collaborators
Medical University of Graz
Lead sponsor
Boehringer Ingelheim
Collaborator
Source ClinicalTrials.gov